Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Study of Bleeding With Extended Administration of an Oral Contraceptive

ClinicalTrials.gov ID: NCT00338052

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00338052. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 12:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg / Ethinyl Estradiol 20 Mcg Oral Tablets

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.

Study identification

NCT ID
NCT00338052
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Warner Chilcott
Industry
Enrollment
207 participants

Conditions and interventions

Eligibility (public fields only)

Age range
25 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2006 (Type not available)
Primary completion
May 2007 (Actual)
Completion
May 2007 (Actual)
Last update posted
May 8, 2008

2006 – 2007

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Warner Chilcott Investigational Site Phoenix Arizona 85031 —
Warner Chilcott Investigational Site Phoenix Arizona 85050 —
Warner Chilcott Investigational Site Tempe Arizona 85283 —
Warner Chilcott Investigational Site Carmichael California 95608 —
Warner Chilcott Investigational Site Boynton Beach Florida 33437 —
Warner Chilcott Investigational Site Leesburg Florida 34748 —
Warner Chilcott Investigational Site Miami Florida 33143 —
Warner Chilcott Investigational Site Miami Florida 33186 —
Warner Chilcott Investigational Site West Palm Beach Florida 33401 —
Warner Chilcott Investigational Site Decatur Georgia 30034 —
Warner Chilcott Investigational Site Roswell Georgia 30075 —
Warner Chilcott Investigational Site Peoria Illinois 61615 —
Warner Chilcott Investigational Site Lexington Kentucky 40509 —
Warner Chilcott Investigational Site Louisville Kentucky 40291 —
Warner Chilcott Investigational Site New Bern North Carolina 28562 —
Warner Chilcott Investigational Site Winston-Salem North Carolina 27103 —
Warner Chilcott Investigational Site Philadelphia Pennsylvania 19114 —
Warner Chilcott Investigational Site Greenville South Carolina 29607 —
Warner Chilcott Investigational Site Pleasant Grove Utah 84062 —
Warner Chilcott Investigational Site Salt Lake City Utah 84017 —
Warner Chilcott Investigational Site Sandy City Utah 84070 —
Warner Chilcott Investigational Site Virginia Beach Virginia 23456 —
Warner Chilcott Investigational Site Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00338052, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2008 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.